Circulating vitamin D and risk of epithelial ovarian cancer

Journal of Oncology

Volumn , Issue , 2009, Pages

  Arslan, Alan A ^a,b   Clendenen, Tess V ^a   Koenig, Karen L ^a   Hultdin, Johan ^c   Enquist, Kerstin ^c   Gren, Sa ^c   Lukanova, Annekatrin ^d   Sjodin, Hubert ^c   Zeleniuch Jacquotte, Anne ^a   Shore, Roy E ^e   Hallmans, Gran ^c   Toniolo, Paolo ^a   Lundin, Eva ^c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c UMEÅ UNIVERSITY   (Sweden)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D RECEPTOR;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER INVASION; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; EPITHELIAL OVARY CANCER; FEMALE; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; VITAMIN BLOOD LEVEL;

EID: 70349249465     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2009/672492     Document Type: Article

References (52)

1. Dokoh S., Donaldson C. A., Marion S. L., Pike J. W., Haussler M. R., The ovary: a target organ for 1,25-dihydroxyvitamin D3 Endocrinology 1983 112 1 200 206
2. Saunders D. E., Christensen C., Williams J. R., Inhibition of breast and ovarian carcinoma cell growth by 1,25-dihydroxyvitamin D3 combined with retinoic acid or dexamethasone Anti-Cancer Drugs 1995 6 4 562 569
3. Jiang F., Li P., Fornace A. J. Jr., Nicosia S. V., Bai W., G2/M arrest by 1,25-dihydroxyvitamin D3 in ovarian cancer cells mediated through the induction of GADD45 via an exonic enhancer Journal of Biological Chemistry 2003 278 48 48030 48040
4. Jiang F., Bao J., Li P., Nicosia S. V., Bai W., Induction of ovarian cancer cell apoptosis by 1,25-dihydroxyvitamin D3 through the down-regulation of telomerase Journal of Biological Chemistry 2004 279 51 53213 53221
5. Li P., Li C., Zhao X., Zhang X., Nicosia S. V., Bai W., p27(Kip1) stabilization and G(1) arrest by 1,25-dihydroxyvitamin D(3) in ovarian cancer cells mediated through down-regulation of cyclin E/cyclin-dependent kinase 2 and Skp1-Cullin-F-box protein/Skp2 ubiquitin ligase Journal of Biological Chemistry 2004 279 24 25260 25267
6. Zhang X., Jiang F., Li P., Growth suppression of ovarian cancer xenografts in nude mice by vitamin D analogue EB1089 Clinical Cancer Research 2005 11 1 323 328
7. Lefkowitz E. S., Garland C. F., Sunlight, vitamin D, and ovarian cancer mortality rates in US women International Journal of Epidemiology 1994 23 6 1133 1136
8. Grant W. B., An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation Cancer 2002 94 6 1867 1875
9. Freedman D. M., Dosemeci M., McGlynn K., Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case-control study Occupational and Environmental Medicine 2002 59 4 257 262
10. Garland C. F., Mohr S. B., Gorham E. D., Grant W. B., Garland F. C., Role of ultraviolet B irradiance and vitamin D in prevention of ovarian cancer American Journal of Preventive Medicine 2006 31 6 512 514
11. Salazar-Martinez E., Lazcano-Ponce E. C., Lira-Lira G. G., Escudero-De Los Rios P., Hernandez-Avila M., Nutritional determinants of epithelial ovarian cancer risk: a case-control study in Mexico Oncology 2002 63 2 151 157
12. Kushi L. H., Mink P. J., Folsom A. R., Prospective study of diet and ovarian cancer American Journal of Epidemiology 1999 149 1 21 31
13. Bidoli E., Vecchia C. L., Talamini R., Micronutrients and ovarian cancer: a case-control study in Italy Annals of Oncology 2001 12 11 1589 1593 (Pubitemid 34065889)
14. Goodman M. T., Wu A. H., Tung K.-H., Association of dairy products, lactose, and calcium with the risk of ovarian cancer American Journal of Epidemiology 2002 156 2 148 157
15. Koralek D. O., Bertone-Johnson E. R., Leitzmann M. F., Relationship between calcium, lactose, vitamin D, and dairy products and ovarian cancer Nutrition and Cancer 2006 56 1 22 30
16. Genkinger J. M., Hunter D. J., Spiegelman D., Dairy products and ovarian cancer: a pooled analysis of 12 cohort studies Cancer Epidemiology Biomarkers and Prevention 2006 15 2 364 372 (Pubitemid 43342189)
17. Sowers M. R., Wallace R. B., Hollis B. W., Lemke J. H., Parameters related to 25-OH-D levels in a population-based study of women The American Journal of Clinical Nutrition 1986 43 4 621 628
18. Heaney R. P., Davies K. M., Chen T. C., Holick M. F., Janet Barger-Lux M. J., Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol The American Journal of Clinical Nutrition 2003 77 1 204 210
19. Burgaz A., kesson A., ster A., Michalsson K., Wolk A., Associations of diet, supplement use, and ultraviolet B radiation exposure with vitamin D status in Swedish women during winter The American Journal of Clinical Nutrition 2007 86 5 1399 1404
20. Sahota H., Barnett H., Lesosky M., Raboud J. M., Vieth R., Knight J. A., Association of vitamin D-related information from a telephone interview with 25-hydroxyvitamin D Cancer Epidemiology Biomarkers and Prevention 2008 17 1 232 238
21. Holick M. F., Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease The American Journal of Clinical Nutrition 2004 80 6, supplement 1678S 1688S
22. Zerwekh J. E., Blood biomarkers of vitamin D status The American Journal of Clinical Nutrition 2008 87 4 1087S 1091S
23. Holick M. F., Vitamin D status: measurement, interpretation, and clinical application Annals of Epidemiology 2009 19 2 73 78
24. Wolpowitz D., Gilchrest B. A., The vitamin D questions: how much do you need and how should you get it? Journal of the American Academy of Dermatology 2006 54 2 301 317
25. Tworoger S. S., Lee I.-M., Buring J. E., Rosner B., Hollis B. W., Hankinson S. E., Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of incident ovarian cancer Cancer Epidemiology Biomarkers and Prevention 2007 16 4 783 788
26. Clendenen T. V., Arslan A. A., Koenig K. L., Vitamin D receptor polymorphisms and risk of epithelial ovarian cancer Cancer Letters 2008 260 1-2 209 215
27. Lurie G., Wilkens L. R., Thompson P. J., Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk Cancer Epidemiology Biomarkers and Prevention 2007 16 12 2566 2571
28. Tworoger S. S., Gate M. A., Lee I.-M., Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies Cancer Research 2009 69 5 1885 1891
29. Hallmans G., Agren A., Johansson G., Cardiovascular disease and diabetes in the Northern Sweden Health and Disease Study Cohortevaluation of risk factors and their interactions Scandinavian Journal of Public Health 2003 31 supplement 61 18 24
30. Toniolo P. G., Pasternack B. S., Shore R. E., Endogenous hormones and breast cancer: a prospective cohort study Breast Cancer Research and Treatment 1991 18 supplement 1 S23 S26
31. Toniolo P. G., Levitz M., Zeleniuch-Jacquotte A., A prospective study of endogenous estrogens and breast cancer in postmenopausal women Journal of the National Cancer Institute 1995 87 3 190 197
32. Borkowf C. B., Albert P. S., Abnet C. C., Using lowess to remove systematic trends over time in predictor variables prior to logistic regression with quantile categories Statistics in Medicine 2003 22 9 1477 1493
33. Arunabh S., Pollack S., Yeh J., Aloia J. F., Body fat content and 25-hydroxyvitamin D levels in healthy women Journal of Clinical Endocrinology and Metabolism 2003 88 1 157 161
34. Gomez J. M., Maravall F. J., Gomez N., Navarro M. A., Casamitjana R., Soler J., Relationship between 25-(OH) D3, the IGF-I system, leptin, anthropometric and body composition variables in a healthy, randomly selected population Hormone and Metabolic Research 2004 36 1 48 53
35. Lucas J. A., Bolland M. J., Grey A. B., Determinants of vitamin D status in older women living in a subtropical climate Osteoporosis International 2005 16 12 1641 1648
36. Snijder M. B., van Dam R. M., Visser M., Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women Journal of Clinical Endocrinology and Metabolism 2005 90 7 4119 4123
37. Freedman D. M., Chang S.-C., Falk R. T., Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial Cancer Epidemiology Biomarkers and Prevention 2008 17 4 889 894
38. Brouwer D. A., van Beek J., Ferwerda H., Rat adipose tissue rapidly accumulates and slowly releases an orally-administered high vitamin D dose British Journal of Nutrition 1998 79 6 527 532
39. Blum M., Dolnikowski G., Seyoum E., Vitamin D(3) in fat tissue Endocrine 2008 33 1 90 94
40. Kilkkinen A., Knekt P., Helivaara M., Vitamin D status and the risk of lung cancer: a cohort study in Finland Cancer Epidemiology Biomarkers and Prevention 2008 17 11 3274 3278
41. Feskanich D., Ma J., Fuchs C. S., Plasma vitamin D metabolites and risk of colorectal cancer in women Cancer Epidemiology Biomarkers and Prevention 2004 13 9 1502 1508 (Pubitemid 39202318)
42. Harris S. S., Dawson-Hughes B., The association of oral contraceptive use with plasma 25-hydroxyvitamin D levels Journal of the American College of Nutrition 1998 17 3 282 284
43. Nesby-ODell S., Scanlon K. S., Cogswell M. E., Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third national health and nutrition examination survey, 19881994 The American Journal of Clinical Nutrition 2002 76 1 187 192
44. Ma J., Stampfer M. J., Gann P. H., Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians Cancer Epidemiology Biomarkers and Prevention 1998 7 5 385 390
45. Laaksonen M., Krkkinen M., Outila T., Vanninen T., Ray C., Lamberg-Allardt C., Vitamin D receptor gene BsmI-polymorphism in Finnish premenopausal and postmenopausal women: its association with bone mineral density, markers of bone turnover, and intestinal calcium absorption, with adjustment for lifestyle factors Journal of Bone and Mineral Metabolism 2002 20 6 383 390
46. Macdonald H. M., McGuigan F. E., Stewart A., Large-scale population-based study shows no evidence of association between common polymorphism of the VDR gene and BMD in British women Journal of Bone and Mineral Research 2006 21 1 151 162
47. Lane N. E., Gore L. R., Cummings S. R., Serum vitamin D levels and incident changes of radiographic hip osteoarthritis: a longitudinal study. Study of Osteoporotic Fractures Research Group Arthritis and Rheumatism 1999 42 5 854 860
48. Platz E. A., Leitzmann M. F., Hollis B. W., Willett W. C., Giovannucci E., Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer Cancer Causes and Control 2004 15 3 255 265 (Pubitemid 38988034)
49. Lips P., Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications Endocrine Reviews 2001 22 4 477 501
50. Garland C. F., Garland F. C., Gorham E. D., The role of vitamin D in cancer prevention American Journal of Public Health 2006 96 2 252 261
51. Pedersen J. I., Vitamin D requirement and setting recommendation levelscurrent Nordic view Nutrition Reviews 2008 66 supplement 2 S165 S169
52. Bischoff-Ferrari H. A., Giovannucci E., Willett W. C., Dietrich T., Dawson-Hughes B., Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes The American Journal of Clinical Nutrition 2006 84 1 18 28